Novel acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
申请人:Beutel A. Bruce
公开号:US20060178400A1
公开(公告)日:2006-08-10
The present invention relates to compounds of formula (I),
which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type II diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.